← FDA Drug Approvals (Drugs@FDA)

SCEMBLIX

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2021-10-29

Drug application

FDA Application #

NDA215358

Application type

New Drug Application

Brand name

SCEMBLIX

Generic name

ASCIMINIB

Active ingredients

ASCIMINIB HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2021-10-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown